Integrin α6 marks stem cell-like cells in human liposarcoma 
Abstract
The relapse and resistance to chemo-and radiotherapy are main problems in the treatment of human liposarcoma. It is important to find a functional marker 
Introduction
Liposarcoma is the most common soft tissue sarcoma and accounts for at least 20% of all sarcomas in adults (1). The two major location of liposarcoma are the extremities and the retroperitoneum (2) . Surgery almost serves as the sole therapy for localized liposarcoma and there is few effective treatment option (3).
For high grade liposarcoma such as lipoblastic sarcoma, 100% of local recurrence will be present within 5 years, and half of them had a distant relapse.
Moreover, liposarcoma is highly resistant to chemotherapy and radiotherapy. All these findings suggest the existence of a sub-group of cells with higher tumorigenicity in human liposarcoma.
Extracellular matrix (ECM) proteins are key structural components of the perivascular niche. The proteins are known to play a role in the proliferation and migration of normal stem cells and tumor cells (4) and in liposarcoma progression (5) . One of the functions of ECM in regulating cell behavior is through their receptors on the cell surface called heterodimer integrins, which consist of α and β subunits (6) . Integrin α6, the receptor for the ECM protein laminin, forms heterodimers with integrin β1 or β4. Integrin α6 is highly expressed in gastrointestinal stromal tumors (7) , embryonic, hematopoeitic and neural stem cells (8). Resent studies suggest that integrin α6 is important for the tumourigenicity of stem cell-like subpopulation within breast cancer cells (9) . It is also known that integrin α6-positive cells are enriched in adult prostatic on October 28, 2017. © 2011 American Association for Cancer Research. mct.aacrjournals.org Downloaded from Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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In the present study, for the first time, we established a sub-cell line (SW872-S) derived from human liposarcoma cells SW872 by repeated inoculation approach in nude mice, which showed high tumor initiation ability in vivo. The SW872-S cells revealed higher adhesion ability to laminin but not to fibronectin than SW872 cells did. This result was then linked to the up-regulated expression of integrin α6 in SW872-S cells, which is rarely expressed in normal adipose derived cells (12) . Furthermore, integrin α6 
Materials and Methods

Animals
Six-week-old NCR-nu/nu (nude) female mice were purchased from the Shanghai Laboratory Animal Center (Shanghai, China). They were maintained in pathogenfree condition at 22±2 °C and kept on a 12-h light-dark cycle. Animal welfare and All efforts were made to minimize the animals' suffering and to reduce the number of animals used.
Isolation of high tumorigenicity sub-cell population using repeating inoculation approach SW872 cells at the logarithmic growth phase were suspended in ice-cold PBS to a final density of 10 7 /ml, and injected into the right flank of nude mice with 100 μl.
Six months later, neoplasm formed in 2 of 30 mice. The mice with tumor were then sacrificed and the isolated cells from the tumor tissue were cultured as method mentioned above. These cells were re-inoculated into nude mice after in vitro culture for 5 generations. After 3 times of the repeated inoculation approach, the sub-cell line with high tumorigenicity in vivo was designed as SW872-S cells.
Cell Culture
Human liposarcoma cell line SW872 cells were purchased from the American Type Culture Collection (Rockville, MD). Cells were maintained in L-15 Medium supplemented with 10% fetal bovine serum (FBS, Life Technologies), 100 U/ml penicillin and 100 μg/ml streptomycin and incubated at 37 °C. Integrin α6 marks stem cell-like cells in human liposarcoma 
Cell adhesion assay
The cell adhesion assay was performed as before (Wu et al., 2004) . In brief, 96-well, flat-bottom culture plates were coated with 50 μl of fibronectin (10 μg/ml), laminin (10 μg/ml) (Calbiochem, San Diego, CA), or collagen type I (50 μg/ml) 
Real-time PCR
Quantitative PCR was performed with the ABI Prism 7000 sequence detection system (Applied Biosystems, Foster City, CA) using SYBR Green I dye (Biotium, Integrin α6 marks stem cell-like cells in human liposarcoma 10 well using Oligofectamine (Invitrogen). CD13 siRNA sequences were as follows:
5'-AACGAUCUCUUCAGCACAUCA -3', Luciferase siRNA was used as described before (13) . Integrin α6 specific SMARTpool® siRNA reagent (Dharmacon, IL) was used to knockdown endogenous integrin α6 in cells.
Immunohistochemistry and H&E staining assay.
Immunostaining of Integrin α6 was done using Real Envision Detection kit (Gene Tech Company, Nanjing, China) according to the manufacturer's instructions.
H&E staining in tumor tissues were performed following manufacturer's protocol.
Western blot
Western blot assay was performed as described (13) . Antibodies to Src, Integrin α6 marks stem cell-like cells in human liposarcoma 11 base in the same medium. Fourteen days later, the plates were photographed using a Nikon inverted microscope and colonies (> 50 cells) were counted.
Flow cytometry and cell sorting
Laminin specific integrins (integrin α1, α2, α3, α6, β1, β4) were measured by using Laminin-Specific Integrins Investigator Kit (ECM420, Millipore), isotype- 
Statistical analysis
Data are expressed as mean ± SD. Student's t test was used to evaluate the difference between two groups. Kaplan-Meier method was used to evaluate the survival test. P < 0.05 was considered to be significant. Integrin α6 marks stem cell-like cells in human liposarcoma 13 In order to detect the underlying mechanism of tumor-initiating potential between the two cell lines, we compared the adhesion ability of SW872 and SW872-S cells. SW872-S cells showed higher adherent ability to laminin but not to fibronectin or collagen ( Fig. 2A) , suggesting the involvement of laminin-specific integrins in the sub-line cells. FACS analyzing revealed that among all the binding integrins to laminin, integrin α6 was the only high-expressing one on cell surface of SW872-S cells, while there was a decrease of integrin α1 (Fig. 2B) . Figure 2C showed that among integrin α family, integrin α6 the only higher expression one in SW872-S cells, indicating integrin α6 may contribute largely to the high adhesion ability on laminin of SW872-S cells. Consistent with the result, blocking with integrin α6 specific antibody (Clone: CoH3) significantly inhibited the adhesion of SW872-S cells to laminin in a dose-dependent manner (Fig. 2D) .
Integrin α6 contributes to the increased liposarcoma growth in vitro and in
vivo.
As shown in Fig. 3A , SW872-S cells grew faster than SW872 cells in vitro. To examine the relation of such enhanced cell growth to the increased expression of integrin α6, we divided SW872-S cells into two compartments according to integrin α6 levels (low and high) by FACS sorting and used them for comparison.
After 72-hour culture, the α6 high cells proliferated 2 times as α6 low cells (Fig. 3B) , and knocking down of integrin α6 with its specific smartpool siRNA significantly decreased the growth of SW872-S cells (Fig. 3C) . We then inoculated into right flank of nude mice with 1×10 contained no integrin α6-positive cells (Fig. 4B) . When cultured in serum-free medium, SW872-S cells with integrin α6 high expression still proliferate well and the cell numbers were increased by 6.8 and 15.1 times after 24 and 48 hours, respectively (Fig. 5A) . The SW872-S cells showed an asymmetrical distribution of the integrin α6 expression in a cell as well as in divided daughter cells during cell division (Fig. 5B, left panel) . Further analysis was performed to test the self-renewal ability of integrin α6 cells. The and CD13 were significantly elevated in SW872-S cells, while those of CD90 and CD166 were decreased in the cells (Fig. 6A) . We further identified that in SW872-S cells, the α6 high group displayed 3 times CD13 expression as α6 low group, while there were no significant or just slender changes in the other markers (Fig. 6B) . The co-high expression of integrin α6 and CD13 was found in SW872-S cells about 12 times than in SW872 cells (Fig. 6C, upper level) . The high expression of CD13 could also been observed in integrin α6 high cells (Fig.   6C, lower panel) . In addition, we found that in 23 other human cancer cell lines, 61% ( Supplementary Fig.1 ) of which contained integrin α6-and CD13-double positive sub groups (Supplementary Fig. 2 ). The integrin α6 6D ). Knocking down of CD13 expression induced apoptosis in SW872-S cells (Fig. 6E, upper panel) as well as in some other malignant cancer cells (Supplementary Fig. 3 ). CD13 specific inhibitor bestatin also induced apoptosis in SW872-S cells in dose-dependent manner (Fig. 6E, lower panel) in which the proliferation of both cells were dose-dependently inhibited (Fig. 6F) .
Consistent with the in vitro experiment, 20 mg/kg/day treatment of bestatin could also inhibite the SW872-S cells growth in nude mice (Fig. 6G ).
Discussion
Patients with liposarcoma always suffered from high risk of relapse, and 100% of local recurrence will be present within 5 years such as lipoblastic liposarcoma despite of thorough surgery treatment (14) . This fact lets us to think about if there is a sub-group of cells with high tumorigenicity in human liposarcoma tissues.
In the present study, we tried to generate the possibly existing sub-population by (Fig. 1C) , and specific cell adhesion to laminin but not to fibronectin or collagen type I (Fig. 2A) . This result suggests an involvement of integrin α1 in SW872-S cells seemed to be in less relationship with cell adhesion ability on laminin, at least in our system, for integrin a1 antibody could not inhibit neither SW872 cells nor SW872-S cells adhesion on laminin (data not shown). Furthermore, blocking with integrin α6 specific antibody (Clone CoH3) significantly inhibited the adhesion of SW872-S cells to laminin in vitro (Fig. 2D) , and the tumor growth in vivo (40.77% of inhibition rate) (Fig. 3D) . These findings strongly suggest that the high tumorigenicity of the sub-cell population could be linked to integrin α6 at least as one of the important factors.
In previous studies, integrin α6 has been reported as subunit form heterodimers with either β1 or β4 integrins, which both function as receptors for the laminin family of ECM. Activated α6β1 or α6β4 components then bring extra-cellular signal to active PI3K/Akt pathway or hif dependent pathway, respectively (16) .
High expression of the α6 subunit in women with breast cancer has been demonstrated to be correlated significantly with reduced survival times (9) .
Recently, integrin α6 has been suggested as a potential marker of cancer stem cells in human glioblastoma (11) . In addition, integrin α6 is critical to the selfrenewal and tumor formation of the glioblastoma stem cells, and knocking-down or blocking with α6 specific antibody could significantly inhibit glioblastoma growth in vitro and in vivo (11) . This report is in consistence with our data shown in Fig. 2 , suggesting that integrin α6 may be crucial for initiating tumor growth in some kinds of cancers. 
As reported by D-S. Kim, et. al. , rapid adhering cells of human epidermal keratinocytes with high levels of integrin α6 show a smaller size, which have high ability of colony formation and skin equivalents reconstruction (17) . In our study, we noticed that in SW872-S cells, integrin α6 high sub-group could grow in serumfree medium at least more than 72 hours (Fig. 5A) , and the size of proliferated integrin α6 high cells were also smaller than the others according to FACS analysis (Fig. 5A) . The underlying mechanism, however, remains unknown. Nevertheless, we have evidenced that integrin α6 was distributed asymmetrically on the surface of a cell and the expression level was quite different in divided daughter cells during cell division. This finding suggests that integrin α6 
It should be noted that in some experiments mentioned above, we did not observe the complete blockade of tumor proliferation or growth by silencing integrin α6 or using its specific monoclonal antibody. This could be partially explained by incomplete silence due to technique restriction. We can also assume that it might be due to another factor involved in integrin α6-mediated tumor initiation upon these data. As the evidence for this, Fig. 6B and C showed that integrin α6 co-highly expressed with CD13, which shows a variety of functions of one member of this family, aminopeptidase N (22).
CD13 has been proved to be a transcript target of Ras signaling pathways (23), playing an important role in tumor progression in ovarian carcinoma cells (24). It was also reported that CD13 could block the apoptosis induction by tumor necrosis factor-alpha (25) , and enhance sensitivity of tumor cells to cisplatin (26).
CD13 was also proved to be involved in cell adhesion (27) as well as in endothelial invasion (28) . Recent study made by Haraguchi et al. proved that CD13 may be a therapeutic target in human liver cancer stem cells and inhibition of CD13 by monoclonal antibody could induce cell apoptosis (29) . In the present study, knocking down of CD13 with its specific siRNA induced apoptosis in SW872-S cells (Fig. 6E) , and small molecule inhibitor of CD13 such as bestatin showed higher inhibition rate on SW872-S-integrin α6 high cells (Fig. 6F ). All these results suggest that CD13 may be an essential co-operator in integrin α6 Integrin α6 marks stem cell-like cells in human liposarcoma 21 measured the co-expression of both proteins in 23 other human cancer cell lines.
As the result, we found that 61% (14 in 23) of them contained CD13 and integrin α6 double-positive sub-group cells (Supplementary Fig. 1 ). Knocking down of CD13 induced apoptosis in A375, A549 and Bel-7402 cells with CD13 and integrin α6 co-high expression (Supplementary Fig. 3) . These results indicate a possibility that both integrin α6 and CD13 may serve as functional markers of not only liposarcoma but also various human cancers and sarcomas, which may be new therapeutic targets for the clinical cancer treatment. Integrin α6 marks stem cell-like cells in human liposarcoma
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